serinc3 serinc5 restrict hiv- infectivity counteracted nef 
hiv- nef unrelated mouse leukaemia virus glycosylated gag glycogag strongly enhance infectivity hiv- virions produced certain cell types clathrin-dependent manner show nef glycogag prevent incorporation multipass transmembrane proteins serine incorporator serinc3 serinc5 hiv- virions extent correlates infectivity enhancement silencing serinc3 serinc5 precisely phenocopied effects nef glycogag hiv- infectivity infectivity nef-deficient virions increased -fold produced double-knockout human cd4+ t cells lack serinc3 serinc5 re-expression experiments confirmed absence serinc3 serinc5 accounted infectivity enhancement furthermore serinc3 serinc5 together restricted hiv- replication restriction evaded nef serinc3 serinc5 highly expressed primary human hiv- target cells inhibiting downregulation nef potential strategy combat hiv/aids 
